Therapy News and Research

RSS

Genetic profiles obtained from nasal passages guide individualized therapy, research

It has become increasingly clear in recent years that asthma comes in several variations, with different causes, different pathologies and different responses to therapy.

20 Feb 2014

BONESUPPORT launches new registry to collect data of CERAMENT™|G to protect bone infections

BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today the launch of a new registry to collect long term data of CERAMENT™|G, the first injectable antibiotic eluting, osteoconductive, ceramic bone substitute indicated to promote and protect bone healing being jeopardized by infection.

20 Feb 2014

CardioCell announces new clinical trials using allogeneic stem-cell therapy to treat subjects with AMI

CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.

20 Feb 2014

NYU Langone and SonaCare Medical join forces to advance therapeutic ultrasound technology

NYU Langone Medical Center and SonaCare Medical, LLC (SonaCare Medical), a global leader in minimally invasive focused therapeutic ultrasound technologies, announced a collaboration to develop tools and clinical procedures based on the use of advanced focused therapeutic ultrasound technology.

20 Feb 2014

Deficiency in SNX27 explains learning impairment in Down's syndrome

Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have identified the precise role of the protein, SNX27, in the pathway leading to memory and learning impairment.

20 Feb 2014

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

An antidepressant medication has shown potential in treating symptoms of agitation that occur with Alzheimer's disease and in alleviating caregivers' stress, according to a multi-site U.S.- Canada study.

20 Feb 2014

DHS expands business and product offerings with the acquisition of Reliable Home Medical Equipment

Dynamic Healthcare Services, Inc., a portfolio company of GMH Ventures LLC and Lakewood Capital, LLC, announced today that it acquired Reliable Home Medical Equipment, Inc. of Hackensack, NJ on February 10th, 2014. The terms of the acquisition were not disclosed.

20 Feb 2014

Researcher receives Pioneer Award for engineering herpes simplex virus gene delivery systems

Joseph C. Glorioso, III, PhD (University of Pittsburgh School of Medicine, PA) devoted much of his research career to developing herpes viruses as efficient vectors for delivering therapeutic genes into cells.

20 Feb 2014

Cystinosis Research Foundation granted $2.15M in 2013 to researchers investigating cure for cystinosis

The Cystinosis Research Foundation awarded $2,153,048 in 2013 to researchers investigating better treatments and a cure for cystinosis, a rare metabolic and genetic disease that afflicts about 500 children and young adults in the United States and 2,000 worldwide.

19 Feb 2014

Indacaterol/glycopyrronium drug combination offers added benefit for adults with COPD

The drug combination indacaterol/glycopyrronium (trade name: Ultibro Breezhaler, Xoterna Breezhaler) has been approved since September 2013 for adults with chronic obstructive pulmonary disease (COPD).

19 Feb 2014

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.

19 Feb 2014

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

Nintedanib plus docetaxel offers significant efficacy in patients with non-small-cell lung cancer who experience disease progression after first-line chemotherapy, phase III study results show.

19 Feb 2014

How do people become depressed? An interview with Anna Watters and Professor Lea Williams, University of Sydney

A clinical diagnosis of depression (i.e. major depressive disorder) is currently defined on the basis of reported symptoms.

19 Feb 2014

Ticks infected with the bacterium that causes Lyme disease widespread in San Francisco Bay Area

As winter turns to spring and many Northern Californians plan outdoor adventures, a mysterious, potentially debilitating threat looms.

19 Feb 2014

Study shows one-quarter of high risk patients do not receive anticoagulants after ablation of AF

One-quarter of high risk patients do not receive anticoagulants after ablation of atrial fibrillation (AF), according to the latest survey of European practice.

19 Feb 2014

FDA approves CSC’s Phase II clinical trial for cancer immunotherapy in women with ovarian cancer

California Stem Cell, Inc. (CSC) announced today that the U.S. Food and Drug Administration (FDA) has approved the Company's application to begin a Phase II clinical trial exploring the potential of a patient-specific cancer immunotherapy in women with Stage III or IV ovarian, fallopian tube or primary peritoneal cancer.

19 Feb 2014

Study examines brain activity of alcohol-dependent women

A new Indiana University study that examines the brain activity of alcohol-dependent women compared to women who were not addicted found stark and surprising differences, leading to intriguing questions about brain network functions of addicted women as they make risky decisions about when and what to drink.

19 Feb 2014

Duke researchers getting closer to generate replacement cartilage

By combining a synthetic scaffolding material with gene delivery techniques, researchers at Duke University are getting closer to being able to generate replacement cartilage where it's needed in the body.

19 Feb 2014

Majority of women who undergo mastectomy go on to get breast reconstruction

A new study finds that the majority of women who undergo mastectomy for breast cancer go on to get breast reconstruction, a practice that has increased dramatically over time.

19 Feb 2014

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).

19 Feb 2014

Therapy News and Research

Genetic profiles obtained from nasal passages guide individualized therapy, research

BONESUPPORT launches new registry to collect data of CERAMENT™|G to protect bone infections

CardioCell announces new clinical trials using allogeneic stem-cell therapy to treat subjects with AMI

NYU Langone and SonaCare Medical join forces to advance therapeutic ultrasound technology

Deficiency in SNX27 explains learning impairment in Down's syndrome

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

DHS expands business and product offerings with the acquisition of Reliable Home Medical Equipment

Researcher receives Pioneer Award for engineering herpes simplex virus gene delivery systems

Cystinosis Research Foundation granted $2.15M in 2013 to researchers investigating cure for cystinosis

Indacaterol/glycopyrronium drug combination offers added benefit for adults with COPD

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

How do people become depressed? An interview with Anna Watters and Professor Lea Williams, University of Sydney

Ticks infected with the bacterium that causes Lyme disease widespread in San Francisco Bay Area

Study shows one-quarter of high risk patients do not receive anticoagulants after ablation of AF

FDA approves CSC’s Phase II clinical trial for cancer immunotherapy in women with ovarian cancer

Study examines brain activity of alcohol-dependent women

Duke researchers getting closer to generate replacement cartilage

Majority of women who undergo mastectomy go on to get breast reconstruction

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News